We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Outlines FDA’s Approach to Precision Medicines
Gottlieb Outlines FDA’s Approach to Precision Medicines
FDA Commissioner Scott Gottlieb spoke about the regulatory challenges of precision medicines and the agency’s plans to focus on durability and safety issues, in a panel discussion at the World Economic Forum in Davos, Switzerland.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor